| Literature DB >> 25221871 |
Pollyanna A S White1, Rita C M Oliveira2, Aldeidia P Oliveira2, Mairim R Serafini3, Adriano A S Araújo4, Daniel P Gelain5, Jose C F Moreira6, Jackson R G S Almeida7, Jullyana S S Quintans8, Lucindo J Quintans-Junior9, Marcio R V Santos10.
Abstract
Chronic diseases such as cancer, diabetes, neurodegenerative and cardiovascular diseases are characterized by an enhanced state of oxidative stress, which may result from the overproduction of reactive species and/or a decrease in antioxidant defenses. The search for new chemical entities with antioxidant profile is still thus an emerging field on ongoing interest. Due to the lack of reviews concerning the antioxidant activity of lichen-derived natural compounds, we performed a review of the antioxidant potential and mechanisms of action of natural compounds isolated from lichens. The search terms "lichens", "antioxidants" and "antioxidant response elements" were used to retrieve articles in LILACS, PubMed and Web of Science published until February 2014. From a total of 319 articles surveyed, 32 met the established inclusion and exclusion criteria. It was observed that the most common isolated compound studied was usnic acid, cited in 14 out of the 32 articles. The most often described antioxidant assays for the study of in vitro antioxidant activity were mainly DPPH, LPO and SOD. The most suggested mechanisms of action were scavenging of reactive species, enzymatic activation and inhibition of iNOS. Thus, compounds isolated from lichens are possible candidates for the management of oxidative stress, and may be useful in the treatment of chronic diseases.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25221871 PMCID: PMC6271897 DOI: 10.3390/molecules190914496
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Flowchart of included studies. Studies were excluded according to the following exclusion criteria: studies in humans, studies of mixtures of substances or extracts from lichens, review articles, meta-analyses, abstracts, conference proceedings, editorials/letters, case reports.
Characteristics of Included Studies.
| Substance/Chemical Class | Authors, Year, Country | Source | Assay | Activity | Results/Mechanism of Action |
|---|---|---|---|---|---|
| Usnic acid | Marante | Antibacterial, anticarcinogenic and antioxidant | Anti-proliferative effect against U937 and HL-60 | ||
| Santos | Immunostimulatory | Induced greatest release of NO in peritoneal macrophages. | |||
| Odabasoglu | Gastroprotective | Increased SOD, GPx, GSH and cNOS activities and reduced CAT, GR, LPO, iNOS and MPx activities | |||
| Dévéhat | No significant activity | – | |||
| Jin, Li and He [ | Anti-inflammatory | Dose-dependent inhibitory effect on LPS-induced TNF-α and NO production in macrophages RAW 264.7, associated with decreased synthesis of TNF-α mRNA and iNOS protein | |||
| De Paz | Antioxidant and neuroprotective | Reduced radical oxygen species (ROS) production on hydrogen peroxide-induced damage in U373 MG cells | |||
| Bačkorová | Purchased from Sigma Chemical | Anticarcinogenic | Anti-proliferative action on A2780, MCF-7, SK-BR-3, HT-29, HCT-116 p53−/−, HL-60 and Jurkat. Higher pro-apoptotic activity, supported by the suppression of viability and cell proliferation, correlated more strongly with an increased number of floating cells | ||
| Thadhani | No significant activity | – | |||
| Behera, Mahadik and Morey [ | Cardioprotective | Moderate to strong antioxidant activity, concentration-dependent manner, on the FRSA, NOR) and in LPO. Poor fobrinolytic potencial | |||
| Bessadottir | Autophagy and pH-determined drug distribution | Induced the formation of autophagosomes in human cancer cells, but had minimal effects on normal human fibroblasts. UA-treated cells showed reduced ATP levels and activation of AMP kinase as well as signs of cellular stress. UA is thus likely to trigger autophagosome formation both by energy depletion and stress conditions. | |||
| Brisdelli | Anticarcinogenic | Anti-proliferative effect against MCF-7, HeLa, HCT-116 | |||
| Rabelo | Purchased from Sigma Chemical | Antioxidant and neurotoxicological | Induced cell detachment and loss of viability at higher concentrations (20 µg/mL) of SH-SY5Y cells alone or in the presence of H2O2 or 1% of FBS, related to the increase of intracellular ROS, inducing an oxidative stress scenario | ||
| Polat | Purchased from Sigma Chemical | Antioxidant | Increased TAC in low doses and TOS in a high dose | ||
| Ranković | Antioxidant, antimicrobial and anticarcinogenic | Very strong antioxidant and antimicrobial activities. Antiproliferative activity correlated with an increase in the number of cells in the sub-G1 phase whiled the percentage of cells in the S-phase and G2/M phase remained unchanged compared to the controls. Interestingly, LS174 cells treated with the tested samples showed a significant increase of the sub-G1 phase and concomitant decrease in G2/M was observed, supporting a G1 phase arrest. These results suggested that the compound have a prominent ability to induce apoptosis in FemX and LS174 cells. | |||
| Atranorim(depside) | Marante | Antibacterial, anticarcinogenic and antioxidant | Moderate antibacterial activity against | ||
| Dévéhat | No significant activity | – | |||
| Papadopoulou | Antioxidant | Antioxidant effect due to an additional hydroxyl group on the aromatic ring were the most active ones | |||
| Bačkorová | Purchased from Sigma Chemical Co. | Anticarcinogenic | Evoked cytotoxicity in HL-60, A2780, MCF-7, SK-BR-3, HT-29, HCT-116 p53−/−, HCT-116 p53+/+ and Jurkat, triggered by higher pro-apoptotic activity (except on A2780 cell line), and supported by the inhibition of clonogenic ability and cell proliferation | ||
| Thadhani | No significant activity | – | |||
| Melo | Antioxidant, cytoprotective and pro-oxidative | Superoxide dismutase-like and scavenging activity of peroxyl radicals. Induce cytoprotection in the presence of toxic concentrations of H2O2 on the SH-SY5Y cells. Conversely, it presented a pro-oxidant capacity in a lipid-rich system, enhancing TBARS and also enhanced production of NO and H2O2 in higher concentrations | |||
| Barreto | Wound healing | Topical application of atranorin reduced wound areas, induced earlier granulation tissue formation, increased cell proliferation, improved collagenization and modulated the myofi broblasts differentiation when compared to control animals. | |||
| Kosanić | Antioxidant, antimicrobial and anticarcinogenic | Very strong antioxidant and antimicrobial activities. Antiproliferative activity accompanied by a stronger increase in the percentage of the sub-G1 population and concomitant decrease in G2/M of FemX and LS174 cell lines, leading to a G0/G1 cell cycle block and inducing apoptosis in a cell cycle-dependent manner | |||
| Diffractaic acid | Santos | Immunostimulatory | Induced greatest release of NO in peritoneal macrophages | ||
| Bayir | Antioxidant and gastroprotective | Decreased MPx, iNOS and LPO and increased cNOS, SOD, GPx and GSH, inhibiting neutrophil infiltration into gastric mucosal tissues | |||
| Odabasoglu | Anticarcinogenic | Reduced the iNOS and MPx activities and increased SOD, GSH level and caspases (2, 3, 8 and 9) activities in tissue surrounding titanium implants | |||
| Brisdelli | Anticarcinogenic | Antiproliferative activity against HCT-116 cells and reduction of viability in MCF-7 and HeLa cells | |||
| Lecanoric acid | Santos | No significant activity | – | ||
| Jayaprakasha and Rao [ | Antioxidant | Moderate antioxidant activity | |||
| Thadhani | Antioxidant | Presented a high SOR activity, comparable to the standards of Propyl gallate (PG) and Butyrated hydroxyanisole (BHA). And moderate activity on NOR and DPPH. | |||
| Lopes | Antioxidant | Moderate activity with an IC50 of 42.87 ± 1.20 | |||
| Stictic acid (depsidone) | De Paz | Xanthoparmelia camtschadalis | Antioxidant and neuroprotective | Protective effect against U373MG cell line by decreasing ROS production induced by H2O2 | |
| Papadopoulou | Antioxidant | Noteworthy antioxidant activity | |||
| Dévéhat | No significant activity | – | |||
| Lobaric acid | Bhattarai | Antibacterial and antioxidant | Activity against gram-positive bacteria | ||
| Brisdelli | Anticarcinogenic | Anti-proliferative activity against HeLa and HCT cells lines | |||
| Thadhani | Antioxidant | Promising antioxidant activity in SOR assay | |||
| Methyl orsenillate | Jayaprakasha and Rao [ | Antioxidant | Moderate antioxidant activity | ||
| Orsenillic acid | |||||
| Orcinol (1) (Benzenoid) | Thadhani | Antioxidant | Activity in NOR assay | ||
| Orsellinic acid (2) (Benzenoid) | Activity in NOR assay | ||||
| Methyl orsellinate (3) (Benzoic acid derivative) | Activity in NOR assay | ||||
| Methyl haematommate (4) Benzoic acid derivative) | Activity in NOR assay | ||||
| Methyl β-orcinolcarboxylate (5) (Benzoic acid derivative) | Activity in NOR assay | ||||
| Methyl β-orsellinate (Benzoic acid derivative) | Marante | Antibacterial | Activity against | ||
| Protocetraric acid (depsidone) | Manojlović | Antibacterial and anticarcinogenic | Highly antibacterial active and presented strong anticancer activity toward FemX and LS174 cell lines. These activities could be due to its higher phenol content. | ||
| Santos | Immunostimulatory | Higher activity in increasing NO release in macrophage cells. | |||
| Fumarprotocetraric acid (depsidone) | Higher activity in increasing NO and H2O2 release in macrophage cells | ||||
| Dévéhat | Antioxidant | High activity in the SAS and moderate in the DPPH | |||
| Kosanić | Antioxidant, antimicrobial and anticarcinogenic | Strong antioxidant and antimicrobial activities. Antiproliferative activity accompanied by a stronger increase in the percentage of the sub-G1 population and concomitant decrease in G2/M of FemX and LS174 cell lines, inducing apoptosis in a cell cycle-dependent manner | |||
| Cryptostictinolide (Compound 2-C19H16O8 - depsidone) | Dévéhat | Antioxidant | Moderate activity in DPPH | ||
| Compound 1 (C19H14O8, identical to stictic acid–depsidone) | No significant activity | Moderate activity in DPPH | |||
| Cryptostictic acid (Depsidone) | No significant activity | – | |||
| Menegazziaic acid (Depsidone) | No significant activity | – | |||
| Constictic acid (Depsidone) | No significant activity | – | |||
| 3- | No significant activity | – | |||
| Barbatic acid (Depside) | No significant activity | – | |||
| Ergosterol peroxide (Terpenoid) | No significant activity | – | |||
| Peristictic acid (Depsidone) | Antioxidant | – | |||
| Norstictic acid (depsidone) | Antioxidant | High SAS activity | |||
| Ranković | Antioxidant, antimicrobial and anticarcinogenic | Stronger antioxidant and antimicrobial activities. Antiproliferative activity correlated with an increase in the number of cells in the sub-G1 phase whiled the percentage of cells in the S-phase and G2/M phase remained unchanged compared to the controls. Interestingly, LS174 cells treated with the tested samples showed a significant increase of the sub-G1 phase and concomitant decrease in G2/M was observed, supporting a G1 phase arrest. These results suggested that the compound have a prominent ability to induce apoptosis in FemX and LS174 cells. | |||
| Cryptostictinolide (depsidone) | Papadopoulou | No significant activity | – | ||
| Hypotrachynic acid (depside) | Antioxidant | Noteworthy antioxidant activity | |||
| Deoxystictic acid (depsidone) | Antioxidant | Noteworthy antioxidant activity | |||
| 8'-methylconstictic acid (depsidone) | Antioxidant | Noteworthy antioxidant activity | |||
| 8'-methylstictic acid (depsidone) | Antioxidant | Noteworthy antioxidant activity | |||
| 8'-methylmenegazziaic acid (depsidone) | Antioxidant | Noteworthy antioxidant activity | |||
| 8'-ethylstictic acid (depsidone) | Antioxidant | Noteworthy antioxidant activity | |||
| Atranol (benzoic acid derivative) | Marante | Anticarcinogenic | Inhibited the proliferation of U937 and HL-60 and presented dose-dependent antioxidant activity | ||
| Chloroatranol (benzoic acid derivative) | Anticarcinogenic and antioxidant | Inhibited the proliferation of U937 and HL-60 and presented dose-dependent antioxidant activity | |||
| Hematommic acid (benzoic acid derivative) | Antioxidant | Dose-dependent antioxidant activity | |||
| Chlorohematommic acid (benzoic acid derivative) | Antioxidant | Dose-dependent antioxidant activity | |||
| Methyl chlorohematommate (benzoic acid derivative) | Antioxidant | Dose-dependent antioxidant activity | |||
| Ethyl hematommate (benzoic acid derivative) | Anticarcinogenic and antioxidant | Inhibited the proliferation of U937 and HL-60 and presented dose-dependent antioxidant activity | |||
| Ethyl chlorohematommate (benzoic acid derivative) | Antioxidant | Dose-dependent antioxidant activity | |||
| Chloroatranorin (benzoic acid derivative) | Antioxidant | Dose-dependent antioxidant activity | |||
| Methyl hematommate (benzoic acid derivative) | Anticarcinogenic and antioxidant | Inhibited the proliferation of U937 and HL-60 and presented dose-dependent antioxidant activity | |||
| Thadhani |
| Antioxidant | Promising antioxidant activity in NOR | ||
| Montagnetal (benzoic acid derivative) | Antioxidant | Promising antioxidant activity in NOR | |||
| Divericatic acid (depside) | Antioxidant | Significant level of activity in SOR | |||
| Erythrin (depside) | Antioxidant | Promising antioxidant activity in NOR | |||
| Sekikiac acid (depside) | Antioxidant | Significant level of activity in SOR | |||
| Zeorin (Terpenoid) | Antioxidant | Significant level of activity in SOR | |||
| Lobastin (depsidone) | Bhattarai | Antibacterial and Antioxidant | Active against Gram-positive bacteria, B. subtilis and S. aureus. Moderate antioxidant activity compared with the synthetic commercial standard BHT | ||
| Sphaerophorin (depside) | Russo | Antioxidant and Anticarcinogenic | The compounds suppressed the formation of lin DNA and induced a partial recovery of scDNA; showed a dose-dependent superoxide scavenging effect; exhibited a significant inhibitory effect on M14 cell; produced DNA damage, inducing a programmed cell death; increased cas-3 and ROS in a concentrantion-dependent manner. | ||
| Pannarin (depsidone) | |||||
| Psoromic acid (depsidone) | Behera, Mahadik and Morey [ | Cardioprotective | Moderate to strong antioxidant activity, concentration-dependent manner, on the FRSA, NOR and in LPO. Poor fibrinolytic potential | ||
| Isophysodic acid (depsidone) | Pavlović | No significant activity | – | ||
| Physodalic acid (depsidone) | Immunoprotective | Induced thymocytes toxicity mainly through increased ROS levels and decreased MMP | |||
| Stojanović | No significant activity | – | |||
| 3-hydroxyphysodic acid (depsidone) | Pavlović | Immunoprotective | Induced thymocytes toxicity that may lead to intracellular low energy levels with resulted cytotoxicity | ||
| Stojanović | Anticarcinogenic | Anti-proliferative action on HeLa cells | |||
| Physodic acid (depsidone) | Pavlović | Immunoprotective | Induced thymocytes toxicity mainly through increased ROS levels and decreased MMP | ||
| Stojanović | Anticarcinogenic | Anti-proliferative action on HeLa cells | |||
| Kosanić | Antioxidant, antimicrobial and anticarcinogenic | Both compounds showed high antioxidant activity on reducing power and SAS assays, correlated with a high content of total phenol of the acetone extracts of the species from which they were isolated. Very strong antimicrobial (MIC) assay activity against B. mycoides, B. subtilis, | |||
| Evernic acid (depside) | |||||
| Parietin (quinone) | Bačkorová | Anticarcinogenic | Evoked cytotoxicity in A2780, Jurkat and HT-29 human cancer cell lines. Only inhibited some clonogenic ability of HeLa and MCF-7 cell lines. | ||
| Gyrophoric acid (depside) | Anticarcinogenic | Anti-proliferative effect on HL-60, A2780 and Jurkat cells and and slightly pro-apoptotic. | |||
| Vicanicin (depsidones) | Brisdelli | Anticarcinogenic | Induced a significant loss of viability in a dose-dependent manner in HeLa and HCT-116 cells | ||
| Variolaric acid | No significant activity | – | |||
| Protolichesterinic acid (depsidones) | Anticarcinogenic | Stronger cytotoxic activity related to its ability to induce apoptosis in HeLa cells by activating an extrinsic cas-8/-3-mediated as well as intrinsic cas-9/-3-mediated pathway. | |||
| Salazinic acid (depsidone) | De Paz | Antioxidant and neuroprotective | Protective effect against U373MG cell line by decreasing ROS production induced by H2O2 | ||
| Manojlović | Antibacterial and anticarcinogenic | Active against B. mycoides, B. subtilis, | |||
| Santos | Immunostimulatory | Activated the release of H2O2 and NO in the culture of mice peritoneal macrophages. | |||
| Hypostictic acid (depsidone) | No significant activity | – | |||
| Biruloquinone (quinone) | Luo | Neuroprotective | Improved viability the H2O2 and β-amyloid injured PC12 cells. Classified as a a mixed-II inhibitor | ||
| Canarione (quinone) | Kinoshita | Antioxidant | Among them, 7-chlororubrocashmeriquinone showed the strongest potential, although canarione, 7-chlorocanarione also demonstrated high antioxidant activities | ||
| Rubrocashmeriquinone (quinone) | |||||
| 7-Chlororubrocashmeriquinone (quinone) | |||||
| 7-chlorocanarione (quinone) | |||||
| Ramalin (nitrogen compound) | Paudel | Antioxidant and anticarcinogenic | Scavenged DPPH, ABTS•+, NO and H2O2 radicals. Presented capacity in reducing Fe3+ to Fe2+ ions and inhibited tyrosinase activity in murine macrophage | ||
| 1,8-dihydrixy-3-hydroxymethyl-5-methylxanthone (xantone) | Takenaka | Not tested | – | – | |
| 1,2,8-trihydroxy-5-methoxy-3-methylxanthone (xantone) | Antioxidant | Higher scavenging than those well-known antioxidants, α-tocopherol and BHT | |||
| 1,7-dihydroxy-3-methylxanthone (xantone) | – | Low scavenging activity | |||
| 1,5,8-trihydroxy-3-methylxanthone (xantone) | Antioxidant | Higher scavenging than those well-known antioxidants, α-tocopherol and BHT | |||
| 1,8-dihydroxy-5-methoxy-3-methylxanthone (xantone) | – | Low scavenging activity | |||
| Emodin (xantone) | Not tested | – | – | ||
| Sclerotiorin (xantone) | Not tested | – | – |
Definition of abbreviations: A2780 = ovarian carcinoma, ABTS•+ = 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid free radicals, BHA = Butyrated hydroxyanisole, cNOS = constitutive nitric oxide synthase, BHT = 2,6-di(terc-butyl)-4-methylphenol, CAS = caspase, CAT = catalase assay, CCK8 = Cell Counting Kit-8, DCFH-DA = 2',7'-dichlorofluorescein diacetate assay, DNA = deoxyribonucleic acid, DPPH = 2,2-diphenyl-1-picrylhydrazil radical scavenging, Fe+2 = ferrous ion, FemX = human melanoma, FRSA = Free Radical Scavenge Activity, GPx = glutathione peroxidase assay, GR = Glutatione reductase activity, GSH = glutathione assay, H2O2 = hydrogen peroxide, HCT = colon carcinoma, HCT-116 = colon carcinoma, HCT-116 p53−/− = human colon carcinoma p53-null subline, HeLa = cervix adenocarcinoma, HeLa = human cervix adenocarcinoma, HL-60 = human monocytic leukemia, HMGR = Hydroxy-3-methyl-glutaryl-CoA reductase, HRS = hydroxyl radical-scavenging activity, HT-29 = human colon adenocarcinoma, HTCA = human tumor clonogenic assay, iNOS = Inducible nitric oxide synthase, Jurkat = human T cells lymphocyte leukaemia, LPO = lipid peroxidation assay, LS174 = human colon carcinoma, M14 = melanoma, MCF-7 = breast adenocarcinoma, MIC = Minimum inhibitory concentration assay, MMP = mitochondrial membrane potential assay, MPx = Myeloperoxidase, MTT = [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], NO = nitric oxide, NOR = nitric oxide radical scavenging, ORAC = Oxygen Radical Absorbance Capacity, PC12 = Rat adrenal phaeochromocytoma, PG = Propyl gallate, ROS = reactive oxygen species, SAS = Superoxide anion scavenging assay, SH-SY5Y = neuroblastoma, SK-BR-3 = Human breast adenocarcinoma, SOD = superoxide dismutase assay, SOR = superoxide radical scavenging, TAC = Total antioxidant capacity, TAC = Total antioxidant capacity, TAR = total antioxidant reactivity index, TBARS = thiobarbituric acid reactive species, TNF-α = tumor necrosis factor-α, TOS = total oxidative status, TRAP = total reactive antioxidant potential index, TUNEL = terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end-labeling, U373MG = Human glioblastoma astrocytoma, U937 = human monocytic leukemia.
Figure 2Usnic acid structure and biological activities.
Figure 3Atranorin structure and biological activities.
Figure 4Lecanoric acid structure and biological activities.
Figure 5Diffractaic acid structure and biological activities.
Figure 6Lobaric acid structure and biological activities.
Figure 7Stictic acid structure and biological activities.
Figure 8Fumarprotocetraric acid structure and biological activities.
Figure 9Salazinic acid structure and biological activities.
Figure 10Physodic acid structure and biological activities.
Figure 11Structures and biological activities of orsellinic acid, methyl orsellinate, orcinol and methyl-β-orcinolcarboxylate, respectively.